SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

AstraZeneca Pharma India informs about Press Release

30 May 2015 Evaluate

AstraZeneca Pharma India has informed about Press Release dated May 29, 2015 titled ‘AstraZeneca Pharma India Limited and Dr Reddy’s Laboratories Limitedenter distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 Diabetes’.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma Share Price

8427.55 20.95 (0.25%)
22-Jun-2026 10:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1840.35
Dr. Reddys Lab 1278.80
Cipla 1396.70
Zydus Lifesciences 1068.95
Lupin 2367.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: